Designing and combining chimeric antigen receptors for improved cellular immunotherapy of hematological malignancies

Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2024,239 p.
Author(s)

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study

Source
PLoS ONE - ISSN 1932-6203-19:7 (2024) p. 1-15
Author(s)

Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma : protocol of a monocentric phase I/II clinical trial in Belgium

Source
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
Author(s)